Susquehanna International Group
AGTC

Susquehanna International Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Susquehanna International Group’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-42,200
Closed -$80K – 14420
2021
Q4 		$80K Sell
42,200
-12,800
-23% -$30.7K ﹤0.01% 12292
2021
Q3 		$166K Buy
55,000
+12,700
+30% +$45.2K ﹤0.01% 11703
2021
Q2 		$165K Sell
42,300
-44,100
-51% -$183K ﹤0.01% 11787
2021
Q1 		$438K Buy
86,400
+71,100
+465% +$369K ﹤0.01% 9781
2020
Q4 		$63K Sell
15,300
-8,300
-35% -$40.8K ﹤0.01% 10686
2020
Q3 		$115K Buy
+23,600
New +$129K ﹤0.01% 9835
2020
Q2 		– Sell
-16,800
Closed -$55K – 11230
2020
Q1 		$55K Buy
+16,800
New +$88.5K ﹤0.01% 9649
2017
Q4 		– Sell
-26,700
Closed -$105K – 10113
2017
Q3 		$105K Buy
26,700
+9,000
+51% +$41.3K ﹤0.01% 8342
2017
Q2 		$90K Sell
17,700
-8,400
-32% -$47.2K ﹤0.01% 8728
2017
Q1 		$180K Buy
26,100
+14,800
+131% +$116K ﹤0.01% 8090
2016
Q4 		$106K Buy
+11,300
New +$102K ﹤0.01% 9058

Susquehanna International Group's AGTC Position: Q4 2022 in Review

Susquehanna International Group sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 20,512 shares — an estimated $6K sold.

Susquehanna International Group first reported a position in AGTC in Q4 2016 and held it in 14 quarters. The position peaked at $797K in Q2 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • Susquehanna International Group reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 20,512 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $6K.
  • Susquehanna International Group first reported a position in Applied Genetic Technologies Corporation in Q4 2016 and held it in 14 quarters.
  • Susquehanna International Group's Applied Genetic Technologies Corporation position peaked at $797K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.